Patent: 5,527,814
Summary for Patent: 5,527,814
| Title: | Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis |
| Abstract: | Use of 2-amino-6-(trifluoromethoxy)benzothiazole, or a salt of this compound with a pharmaceutically acceptable acid, for obtaining a medicament intended for the treatment of motor neuron diseases, in particular amyotrophic lateral sclerosis, and especially amyotrophic lateral sclerosis with early bulbar involvement or the bulbar form of the disease. |
| Inventor(s): | Erik Louvel |
| Assignee: | Covis Pharma GmbH |
| Application Number: | US08/327,343 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,527,814
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Corza Medical Gmbh | TACHOSIL | fibrin sealant patch | Patch | 125351 | April 5, 2010 | ⤷ Start Trial | 2014-10-21 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
